By integrating its cutting-edge genetic testing solutions, LH is now able to offer more comprehensive patient insights, covering everything from testing and diagnosis to treatment. In the oncology area, Labcorp's status as the only provider of FDA-authorized kitted solutions for both tissue and liquid-based solid tumor testing is likely to have secured its competitive edge, contributing to the fourth-quarter top line.